Yvonne Greenstreet

Chief Executive Officer, Alnylam Pharmaceuticals

About

Yvonne Greenstreet is the chief executive officer of Alnylam Pharmaceuticals, a biopharmaceutical company whose products include Amvuttra, Onpattro, Givlaari and Oxlumo. Alnylam's third-quarter 2026 results release, dated October 29, 2026, quotes her as CEO. The company's 2026 proxy statement says she has served as CEO since January 2022 and as a director since October 2021, after serving as chief operating officer and then president and chief operating officer.

Greenstreet is a physician. Alnylam's leadership page says she earned a medical degree from the University of Leeds and holds an MBA from INSEAD. According to the proxy statement she worked for 18 years at GlaxoSmithKline, then was head of Medicines Development at Pfizer from December 2010 to November 2013, and founded Highgate LLC in 2014. She joined Alnylam as chief operating officer in September 2016. Other pharmaceutical leaders with pages on Whoo include Vas Narasimhan of Novartis and Pascal Soriot of AstraZeneca.

Whoo compiled this page from public sources: Alnylam third-quarter 2026 results release (SEC), Alnylam 2026 proxy statement (SEC), Alnylam leadership page, Wikipedia. It is not affiliated with or endorsed by Yvonne Greenstreet. Are you Yvonne Greenstreet? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Chief Executive Officer — Alnylam Pharmaceuticals


January 2022 – Present

  • Board member since October 2021
  • President and Chief Operating Officer — Alnylam Pharmaceuticals


    October 2020 – January 2022

    Chief Operating Officer — Alnylam Pharmaceuticals


    September 2016 – October 2020

    Founder and Managing Director — Highgate LLC


    January 2014 – August 2016

    Senior Vice President and Head of Medicines Development — Pfizer


    December 2010 – November 2013

    Various roles — GlaxoSmithKline

  • Worked there for 18 years; most recently Senior Vice President and Chief of Strategy for Research and Development

Education

Medical degree — University of Leeds

MBA — INSEAD


Projects